Thomas Carr Scanlon
1Patents
1Active
1Granted
36Portfolio score
Filing activity: Jul 6, 2015 → Jul 6, 2015
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9950041B2 | Therapeutic charge engineered variants of lysozyme and methods for using same to treat infections | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.